Skip to main content
Journal cover image

Obese asthmatic patients have decreased surfactant protein A levels: Mechanisms and implications.

Publication ,  Journal Article
Lugogo, N; Francisco, D; Addison, KJ; Manne, A; Pederson, W; Ingram, JL; Green, CL; Suratt, BT; Lee, JJ; Sunday, ME; Kraft, M; Ledford, JG
Published in: J Allergy Clin Immunol
March 2018

BACKGROUND: Eosinophils are prominent in some patients with asthma and are increased in the submucosa in a subgroup of obese patients with asthma (OAs). Surfactant protein A (SP-A) modulates host responses to infectious and environmental insults. OBJECTIVE: We sought to determine whether SP-A levels are altered in OAs compared with a control group and to determine the implications of these alterations in SP-A levels in asthmatic patients. METHODS: Bronchoalveolar lavage fluid from 23 lean, 12 overweight, and 20 obese subjects were examined for SP-A. Mouse tracheal epithelial cells grown at an air-liquid interface were used for mechanistic studies. SP-A-/- mice were challenged in allergen models, and exogenous SP-A therapy was given after the last challenge. Eosinophils were visualized and quantitated in lung parenchyma by means of immunostaining. RESULTS: Significantly less SP-A (P = .002) was detected in samples from OAs compared with those from control subjects. A univariable regression model found SP-A levels were significantly negatively correlated with body mass index (r = -0.33, P = .014), whereas multivariable modeling demonstrated that the correlation depended both on asthma status (P = .017) and the interaction of asthma and body mass index (P = .008). Addition of exogenous TNF-α to mouse tracheal epithelial cells was sufficient to attenuate SP-A and eotaxin secretion. Allergen-challenged SP-A-/- mice that received SP-A therapy had significantly less tissue eosinophilia compared with mice receiving vehicle. CONCLUSIONS: SP-A functions as an important mediator in resolving tissue and lavage fluid eosinophilia in allergic mouse models. Decreased levels of SP-A in OAs, which could be due to increased local TNF-α levels, might lead to impaired eosinophil resolution and could contribute to the eosinophilic asthma phenotype.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Allergy Clin Immunol

DOI

EISSN

1097-6825

Publication Date

March 2018

Volume

141

Issue

3

Start / End Page

918 / 926.e3

Location

United States

Related Subject Headings

  • Pulmonary Surfactant-Associated Protein A
  • Obesity
  • Middle Aged
  • Mice, Knockout
  • Mice
  • Male
  • Lung
  • Humans
  • Female
  • Bronchoalveolar Lavage Fluid
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lugogo, N., Francisco, D., Addison, K. J., Manne, A., Pederson, W., Ingram, J. L., … Ledford, J. G. (2018). Obese asthmatic patients have decreased surfactant protein A levels: Mechanisms and implications. J Allergy Clin Immunol, 141(3), 918-926.e3. https://doi.org/10.1016/j.jaci.2017.05.028
Lugogo, Njira, Dave Francisco, Kenneth J. Addison, Akarsh Manne, William Pederson, Jennifer L. Ingram, Cynthia L. Green, et al. “Obese asthmatic patients have decreased surfactant protein A levels: Mechanisms and implications.J Allergy Clin Immunol 141, no. 3 (March 2018): 918-926.e3. https://doi.org/10.1016/j.jaci.2017.05.028.
Lugogo N, Francisco D, Addison KJ, Manne A, Pederson W, Ingram JL, et al. Obese asthmatic patients have decreased surfactant protein A levels: Mechanisms and implications. J Allergy Clin Immunol. 2018 Mar;141(3):918-926.e3.
Lugogo, Njira, et al. “Obese asthmatic patients have decreased surfactant protein A levels: Mechanisms and implications.J Allergy Clin Immunol, vol. 141, no. 3, Mar. 2018, pp. 918-926.e3. Pubmed, doi:10.1016/j.jaci.2017.05.028.
Lugogo N, Francisco D, Addison KJ, Manne A, Pederson W, Ingram JL, Green CL, Suratt BT, Lee JJ, Sunday ME, Kraft M, Ledford JG. Obese asthmatic patients have decreased surfactant protein A levels: Mechanisms and implications. J Allergy Clin Immunol. 2018 Mar;141(3):918-926.e3.
Journal cover image

Published In

J Allergy Clin Immunol

DOI

EISSN

1097-6825

Publication Date

March 2018

Volume

141

Issue

3

Start / End Page

918 / 926.e3

Location

United States

Related Subject Headings

  • Pulmonary Surfactant-Associated Protein A
  • Obesity
  • Middle Aged
  • Mice, Knockout
  • Mice
  • Male
  • Lung
  • Humans
  • Female
  • Bronchoalveolar Lavage Fluid